Michael Clayman

Michael Clayman

Ordförande på
Anokion SA
74 år
Health Technology
Consumer Services
Industrial Services

Profil

Michael D.
Clayman
is the founder of Flexion Therapeutics, Inc., which was founded in 2007.
He held the title of President, Chief Executive Officer & Director from 2018 to 2021.
Currently, he is the Non-Executive Chairman at Anokion SA since 2016, Chairman at Ribometrix, Inc. since 2019, Chairman at Nido Biosciences, Inc. since 2022, and Director at Kanyos Bio, Inc. He previously worked as an Independent Director at Akebia Therapeutics, Inc. from 2014 to 2018.
He also held positions at Eli Lilly & Co., Abbott Cardiovascular Systems, Inc., Chorus Group Ltd., Lilly Research Laboratories, and Perelman School of Medicine.
He completed his undergraduate degree at Yale University and obtained a doctorate from UC San Diego School of Medicine.

Aktiva positioner av Michael Clayman

FöretagPositionStart
Ordförande 2018-06-14
Direktör/Styrelseledamot -
Ordförande 2019-09-27
Ordförande 2022-08-01

Tidigare kända positioner av Michael Clayman

FöretagPositionSlut
FLEXION THERAPEUTICS, INC. Verkställande Direktör 2021-11-19
AKEBIA THERAPEUTICS, INC. Direktör/Styrelseledamot 2018-12-12
Företagsledare/Principal 2007-01-01
Generell Rådgivare -
ELI LILLY AND COMPANY Företagsledare/Principal -
Se detaljerna i Michael Claymans erfarenhet

Michael Claymans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

63

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Health Technology

Health Technology

Health Technology

Industrial Services

Consumer Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Michael Clayman